Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study.
Costs and quality of life in multiple sclerosis patients with spasticity.
Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population.
Contrast-Enhanced MR Imaging in Neuroimaging.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
Therapies for multiple sclerosis: translational achievements and outstanding needs.
Management of multiple sclerosis.
Early detection of thrombin activity in neuroinflammatory disease.
A task-oriented circuit training in multiple sclerosis: a feasibility study.
Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
Multimodal Therapy of Recurrent Severe Acute Disseminated Encephalomyelitis: The Role of Immunoadsorption.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
Utilized Resources of Hope, Orientation, and Inspiration in Life of Persons with Multiple Sclerosis and Their Association with Life Satisfaction, Adaptive Coping Strategies, and Spirituality.
Orientation Dependent MR Signal Decay Differentiates between People with MS, Their Asymptomatic Siblings and Unrelated Healthy Controls.
Pages
« first
‹ previous
…
553
554
555
556
557
558
559
560
561
…
next ›
last »